BCL2L1 and ovarian cancer: This analysis indicated that ovarian cancers with high BCLXL mRNA in GEPIA tended to have shorter survival, and patients with high PUMA mRNA in Kmplot tended to be associated with shorter survival (Supplementary Fig. 6c, d).